A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
Clinical trial NCT04292912 · TERMINATED
Trial details
- NCT number
- NCT04292912
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-07
- Primary completion
- 2022-04-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.